272 related articles for article (PubMed ID: 36309355)
21. Biology of HPV Mediated Carcinogenesis and Tumor Progression.
Cosper PF; Bradley S; Luo L; Kimple RJ
Semin Radiat Oncol; 2021 Oct; 31(4):265-273. PubMed ID: 34455982
[TBL] [Abstract][Full Text] [Related]
22. Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression.
Liu H; Liang H; Li D; Wang M; Li Y
Microbiol Spectr; 2022 Oct; 10(5):e0015122. PubMed ID: 36036584
[TBL] [Abstract][Full Text] [Related]
23. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.
Buonomo T; Carraresi L; Rossini M; Martinelli R
J Transl Med; 2011 Jan; 9():2. PubMed ID: 21205295
[TBL] [Abstract][Full Text] [Related]
24. YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia.
Hatterschide J; Castagnino P; Kim HW; Sperry SM; Montone KT; Basu D; White EA
Elife; 2022 Feb; 11():. PubMed ID: 35170430
[TBL] [Abstract][Full Text] [Related]
25. HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis.
Leung TW; Liu SS; Leung RC; Chu MM; Cheung AN; Ngan HY
J Med Virol; 2015 Jun; 87(6):1022-33. PubMed ID: 25648229
[TBL] [Abstract][Full Text] [Related]
26. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
27. Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention.
Idres YM; McMillan NAJ; Idris A
Mol Diagn Ther; 2022 May; 26(3):301-308. PubMed ID: 35380358
[TBL] [Abstract][Full Text] [Related]
28. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
[TBL] [Abstract][Full Text] [Related]
29. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
31. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.
Fiedler M; Müller-Holzner E; Viertler HP; Widschwendter A; Laich A; Pfister G; Spoden GA; Jansen-Dürr P; Zwerschke W
FASEB J; 2004 Jul; 18(10):1120-2. PubMed ID: 15155561
[TBL] [Abstract][Full Text] [Related]
32. Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer.
Lin Z; Zhao Y; Li Q; Ci X; Ye X; Chen G; Tu Q; Feng W; Jiang P; Zhu S; Xue X; Saunders NA; Zhang L; Zhu X; Zhao KN
Carcinogenesis; 2022 Jun; 43(5):479-493. PubMed ID: 35134836
[TBL] [Abstract][Full Text] [Related]
33. A Comprehensive Review on Cross-talk of Human Papilloma Virus Oncoproteins and Developmental/Self-Renewal Pathways During the Pathogenesis of Uterine Cervical Cancer.
Ahmad A; Ansari IA
Curr Mol Med; 2021; 21(5):402-416. PubMed ID: 32981505
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
Dong D; Zhu Y; Aili Z; Chen Z; Ding J
Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
[TBL] [Abstract][Full Text] [Related]
35. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
Mainguené J; Vacher S; Kamal M; Hamza A; Masliah-Planchon J; Baulande S; Ibadioune S; Borcoman E; Cacheux W; Calugaru V; Courtois L; Crozes C; Deloger M; Girard E; Delord JP; Dubray-Vautrin A; Larbi Chérif L; Dupain C; Jeannot E; Klijanienko J; Lameiras S; Lecerf C; Modesto A; Nicolas A; Rouzier R; Saada-Bouzid E; Saintigny P; Sudaka A; Servant N; Le Tourneau C; Bièche I
Mol Oncol; 2022 Aug; 16(16):3001-3016. PubMed ID: 35398964
[TBL] [Abstract][Full Text] [Related]
36. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
37. Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.
Gutiérrez-Hoya A; Soto-Cruz I
Cells; 2020 Oct; 9(10):. PubMed ID: 33076315
[TBL] [Abstract][Full Text] [Related]
38. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
39. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions.
Chaiwongkot A; Vinokurova S; Pientong C; Ekalaksananan T; Kongyingyoes B; Kleebkaow P; Chumworathayi B; Patarapadungkit N; Reuschenbach M; von Knebel Doeberitz M
Int J Cancer; 2013 May; 132(9):2087-94. PubMed ID: 23065631
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
